| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6182654 | Gynecologic Oncology | 2015 | 7 Pages |
Abstract
For patients with early-stage ovarian cancer, low SES is a significant and independent predictor of deviation from the NCCN guidelines for surgery, chemotherapy, and overall treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Melissa Hodeib, Jenny Chang, Fong Liu, Argyrios Ziogas, Sarah Dilley, Leslie M. Randall, Hoda Anton-Culver, Robert E. Bristow,